Page last updated: 2024-08-24

zileuton and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

zileuton has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bailie, MB; Fink, GD; Pearson, JM; Roth, RA	2
Bolognese, B; Hubbard, WC; Jackson, JR; Mangar, CA; Marshall, LA; Winkler, JD	1
Barberà, JA; Chung, KF; Gómez, FP; Iglesia, R; Roca, J; Rodriguez-Roisin, R	1
Bizer, C; Schapowal, A; Simon, HU; Thomet, OA; Wiesmann, UN	1

Trials

1 trial(s) available for zileuton and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma. American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:5 Pt 1 Topics: Adult; Airway Resistance; Asthma; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Male; Neutropenia; Oxygen; Platelet Activating Factor; Pulmonary Gas Exchange; Respiratory Mechanics; Ventilation-Perfusion Ratio	1998

Article

Year

The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.

American journal of respiratory and critical care medicine, 1998, Volume: 157, Issue:5 Pt 1

Topics: Adult; Airway Resistance; Asthma; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Male; Neutropenia; Oxygen; Platelet Activating Factor; Pulmonary Gas Exchange; Respiratory Mechanics; Ventilation-Perfusion Ratio

1998

Other Studies

4 other study(ies) available for zileuton and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine

Article	Year
Platelet activating factor receptor blockade alone or in combination with leukotriene synthesis inhibition does not ameliorate alpha-naphthylisothiocyanate-induced hepatotoxicity. Toxicology letters, 1996, Volume: 84, Issue:2 Topics: 1-Naphthylisothiocyanate; Animals; Azepines; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Liver; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles	1996
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. Toxicology, 1997, Sep-05, Volume: 121, Issue:3 Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles	1997
The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. Biochimica et biophysica acta, 1998, May-20, Volume: 1392, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Granuloma; Hydroxyurea; Inflammation Mediators; Leukotrienes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenanthridines; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Sulfonamides; Triazines	1998
Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus. Biochemical pharmacology, 2001, Apr-15, Volume: 61, Issue:8 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Asteraceae; Calcium; Complement C5a; Cysteine; Eosinophils; Humans; Hydroxyurea; In Vitro Techniques; Leukotriene B4; Leukotrienes; Macrophages; Neutrophils; Plant Extracts; Platelet Activating Factor; Sesquiterpenes; Signal Transduction	2001